| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |